SEC Form 4 · accession 0001209191-18-016000
HERBALIFE LTD. · HLF
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard P Bermingham
Director
Period of report
Feb 28, 2018
Accepted (ET)
Mar 2, 2018 · 6:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001180262
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Feb 28, 2018 | M | 7,503 | $44.79 | A | 11,087 | D | |
| Common Stock | Feb 28, 2018 | D | 3,649 | $92.10 | D | 7,438 | D | |
| Common Stock | Feb 28, 2018 | M | 4,526 | $79.58 | A | 11,964 | D | |
| Common Stock | Feb 28, 2018 | D | 3,911 | $92.10 | D | 8,053 | D | |
| Common Stock | Mar 2, 2018 | S | 3,800 | $91.77 | D | 4,253 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation Rights | $44.79 | Feb 28, 2018 | M | 7,503 | D | May 31, 2015 | May 31, 2022 | Common Stock | 7,503 | 0 | D |
| Stock Appreciation Rights | $79.58 | Feb 28, 2018 | M | 4,526 | D | Dec 19, 2016 | Dec 19, 2023 | Common Stock | 4,526 | 0 | D |
Explanation of responses
- F1The reporting person received 3,854 shares of common stock upon the net exercise of the 7,503 stock appreciation rights ("SARs"). The reporting person forfeited 3,649 shares of common stock underlying SARs in payment of the exercise price using the closing stock price on February 28, 2018 of $92.10.
- F2Amount of securities beneficially owned following the reported transaction was corrected to add 1,665 shares previously disclosed on the reporting person's Form 4 filed on May 9, 2017.
- F3The reporting person received 615 shares of common stock upon the net exercise of the 4,526 SARs. The reporting person forfeited 3,911 shares of common stock underlying SARs in payment of the exercise price using the closing stock price on February 28, 2018 of $92.10.